Global Nephrology Drugs Market
The global nephrology drugs market is experiencing significant expansion, driven by the increasing prevalence of kidney diseases, aging demographics, and advancements in treatment methods. The market, valued at $14.5 billion in 2020, is projected to reach $23.4 billion by 2030, growing at a CAGR of 5.0% from 2021 to 2030. However, despite strong growth prospects, challenges such as high treatment costs and regulatory barriers persist. This article delves into the key market drivers, segmentation, challenges, and opportunities that shape the future of nephrology drugs.
Comments
Post a Comment